EGFR-SGLT1 interaction does not respond to EGFR modulators, but inhibition of SGLT1 sensitizes prostate cancer cells to EGFR tyrosine kinase inhibitors
2019 ◽
2017 ◽
2008 ◽
Vol 6
(12)
◽
pp. 155
2004 ◽
Vol 22
(14_suppl)
◽
pp. 3138-3138
◽
2004 ◽
Vol 22
(14_suppl)
◽
pp. 3138-3138